sb 216763 has been researched along with Memory Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, L; Hui, J; Jiang, D; Mao, X; Pu, M; Shi, G; Wu, J; Xi, G; Zhang, J; Zhou, X; Zou, J | 1 |
1 other study(ies) available for sb 216763 and Memory Disorders
Article | Year |
---|---|
Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.
Topics: Animals; beta Catenin; Cognitive Dysfunction; Corticosterone; Depressive Disorder; Disease Models, Animal; Gene Transfer Techniques; Glycogen Synthase Kinase 3 beta; Hippocampus; Indoles; Intercellular Signaling Peptides and Proteins; Learning Disabilities; Male; Maleimides; Maze Learning; Memory Disorders; Nootropic Agents; Rats, Sprague-Dawley; Signal Transduction; Stress, Psychological; Uncertainty | 2018 |